Home / Inspections / 1085751

FDA Inspection 1085751 — Geri-Care Pharmaceuticals Corp.

Geri-Care Pharmaceuticals Corp. — FEI 2435388

The FDA completed an inspection of Geri-Care Pharmaceuticals Corp. on March 8, 2019 in Lakewood, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 8, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lakewood, NJ (United States)

Facility

Other inspections at this facility

  • 1269791 (VAI Mon May 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1027069 (NAI Thu Sep 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 886331 (NAI Thu Jun 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 793414 (NAI Thu Aug 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 705311 (NAI Thu Jan 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources